Global clinical development - changing paradigms
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Presentation
- By: OUT, Henk Jan (Schering-Plough, Oss, Netherlands)
The mission from the pharmaceutical industry to bring new medicines to patients is facing many challenges in the 21st century. Increased regulatory and public scrutiny on the drug approval process has led to a misbalance between the investment in R&D and the number of FDA approvals. Pressure on patents and prices of innovative medicines is.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.